Explore why clinicians are raising alarms about generic drug quality. New data links overseas manufacturing to higher adverse events, highlighting gaps in FDA inspections and supply chain transparency.
VIEW MOREExplore the systemic causes of generic drug shortages, from manufacturing failures and API concentration in China and India to the economic pressures of PBMs.
VIEW MORE